» Articles » PMID: 6178757

Catabolic Pathways for Streptokinase, Plasmin, and Streptokinase Activator Complex in Mice. In Vivo Reaction of Plasminogen Activator with Alpha 2-macroglobulin

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1982 Aug 1
PMID 6178757
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The catabolic pathways of streptokinase, plasmin, and activator complex prepared with human plasminogen were studied in mice. (125)I-streptokinase clearance occurred in the liver and was 50% complete in 15 min. Incubation with mouse plasma had no effect on the streptokinase clearance rate. Complexes of plasmin and alpha(2)-plasmin inhibitor were eliminated from the plasma by a specific and saturable pathway. Competition experiments demonstrated that this pathway is responsible for the clearance of injected plasmin. Streptokinase-plasminogen activator complex formed with either (125)I-plasminogen or (125)I-streptokinase cleared in the liver at a significantly faster rate than either of the uncomplexed proteins (50% clearance in <3 min). Streptokinase incubated with human plasma also demonstrated this accelerated clearance. p-Nitrophenyl-p'-guanidinobenzoate-HCl or pancreatic trypsin inhibitor-treated complex cleared slowly compared with untreated complex independent of which protein was radiolabeled. Significant competition for clearance was demonstrated between alpha(2)-macroglobulin-trypsin and activator complex only when the plasmin(ogen) was the radiolabeled moiety. Large molar excesses of alpha(2)-plasmin inhibitor-plasmin failed to retard the clearance of activator complex. Hepatic binding of streptokinase-plasmin, in liver perfusion experiments, was dependent upon prior incubation with plasma (8-10% uptake compared to a background of approximately 2.5%). Substitution of human alpha(2)-macroglobulin for plasma also resulted in binding when the incubation was performed for 10 min at 37 degrees C (7.5%). Electrophoresis experiments confirmed the transfer of 0.8 mol plasmin/mol alpha(2)-macroglobulin when activator complex was incubated at 37 degrees C with alpha(2)-macroglobulin for 40 min. Streptokinase transfer from activator complex to alpha(2)-macroglobulin was negligible. The in vivo clearance of activator complex is proposed to involve active attack of the complex on the alpha(2)-macroglobulin "bait region," resulting in facilitated plasmin transfer. Dissociated streptokinase is rapidly bound and cleared by sites in the liver.

Citing Articles

PAI1 blocks NMDA receptor-mediated effects of tissue-type plasminogen activator on cell signaling and physiology.

Gonias S, Banki M, Gilder A, Azmoon P, Campana W, Mantuano E J Cell Sci. 2018; 131(14).

PMID: 29930084 PMC: 6080607. DOI: 10.1242/jcs.217083.


Pathogen activators of plasminogen.

Verhamme I, Panizzi P, Bock P J Thromb Haemost. 2015; 13 Suppl 1:S106-14.

PMID: 26149011 PMC: 4498406. DOI: 10.1111/jth.12939.


Proteinases are isoform-specific regulators of the binding of transforming growth factor beta to alpha 2-macroglobulin.

Webb D, Weaver A, Gonias S Biochem J. 1996; 320 ( Pt 2):551-5.

PMID: 8973565 PMC: 1217964. DOI: 10.1042/bj3200551.


Differences in the binding of transforming growth factor beta 1 to the acute-phase reactant and constitutively synthesized alpha-macroglobulins of rat.

Webb D, Crookston K, Figler N, LaMarre J, Gonias S Biochem J. 1995; 312 ( Pt 2):579-86.

PMID: 8526873 PMC: 1136301. DOI: 10.1042/bj3120579.


Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.

Fuchs H, Trapp H, Griffith M, Roberts H, Pizzo S J Clin Invest. 1984; 73(6):1696-703.

PMID: 6202716 PMC: 437081. DOI: 10.1172/JCI111377.


References
1.
Wiman B, Collen D . On the kinetics of the reaction between human antiplasmin and plasmin. Eur J Biochem. 1978; 84(2):573-8. DOI: 10.1111/j.1432-1033.1978.tb12200.x. View

2.
Johnson A, McCARTY W . The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase. J Clin Invest. 1959; 38:1627-43. PMC: 293294. DOI: 10.1172/JCI103941. View

3.
Fletcher A, ALKJAERSIG N, SMYRNIOTIS F, Sherry S . The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy. Trans Assoc Am Physicians. 1958; 71:287-96. View

4.
Sottrup-Jensen L, Petersen T, Magnusson S . Mechanism of proteinase complex formation with alpha 2-macroglobulin. Three modes of trypsin binding. FEBS Lett. 1981; 128(1):127-32. DOI: 10.1016/0014-5793(81)81097-6. View

5.
David G, Reisfeld R . Protein iodination with solid state lactoperoxidase. Biochemistry. 1974; 13(5):1014-21. DOI: 10.1021/bi00702a028. View